Interpretation of HLA single antigen bead assays (Q38129992)

29 August 2017

title

Interpretation of HLA single antigen bead assays (English)

1 reference

29 August 2017

Thomas M Ellis

1

1 reference

29 August 2017

publication date

17 August 2013

1 reference

29 August 2017

published in

Transplantation Reviews

1 reference

29 August 2017

volume

27

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

108-111

1 reference

Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Calculated PRA: a process whose time has come or 'Déjà vu' all over again?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Calculated PRA (CPRA): the new measure of sensitization for transplant candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

The DQ barrier: improving organ allocation equity using HLA-DQ information.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Anti-Cw donor-specific alloantibodies can lead to positive flow cytometry crossmatch and irreversible acute antibody-mediated rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Donor-specific antibody against denatured HLA-A1: clinically nonsignificant?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Flow cytometry controls, instrument setup, and the determination of positivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

Donor-specific antibodies adversely affect kidney allograft outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2013.07.001

10.1016/J.TRRE.2013.07.001

7 January 2021

Identifiers

DOI

1 reference

29 August 2017

1 reference